Primary acute myeloid leukemia cells with IDH1 or IDH2 mutations respond to a DOT1L inhibitor in vitro

S. M. Sarkaria; M. J. Christopher; J. M. Klco; T. J. Ley

doi:10.1038/leu.2014.235

Primary acute myeloid leukemia cells with IDH1 or IDH2 mutations respond to a DOT1L inhibitor in vitro

S. M. Sarkaria, M. J. Christopher, J. M. Klco, T. J. Ley

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	2403-2406
Number of pages	4
Journal	Leukemia
Volume	28
Issue number	12
DOIs	https://doi.org/10.1038/leu.2014.235
State	Published - Dec 11 2014

Access to Document

10.1038/leu.2014.235

Cite this

@article{190b086351ab421da051ead4e03af45b,

title = "Primary acute myeloid leukemia cells with IDH1 or IDH2 mutations respond to a DOT1L inhibitor in vitro",

author = "Sarkaria, {S. M.} and Christopher, {M. J.} and Klco, {J. M.} and Ley, {T. J.}",

note = "Funding Information: Technical assistance was provided by the Alvin J. Siteman Cancer Center Tissue Procurement Core, the High Speed Cell Sorter Core, and the Molecular and Genomic Analysis Core at Washington University School of Medicine and Barnes-Jewish Hospital in St Louis, MO, which are all supported by the National Cancer Institute Cancer Center Support Grant P30CA91842. This work was supported by National Institutes of Health grant R01CA162086 (TJL), PO1CA101937 (TJL), K08HL116605 (JMK) and the Barnes Jewish Hospital Foundation (TJL), as well as the Doris Duke Charitable Foundation to Washington University (SMS, Clinical Research Fellow).",

year = "2014",

month = dec,

day = "11",

doi = "10.1038/leu.2014.235",

language = "English",

volume = "28",

pages = "2403--2406",

journal = "Leukemia",

issn = "0887-6924",

number = "12",

}

TY - JOUR

T1 - Primary acute myeloid leukemia cells with IDH1 or IDH2 mutations respond to a DOT1L inhibitor in vitro

AU - Sarkaria, S. M.

AU - Christopher, M. J.

AU - Klco, J. M.

AU - Ley, T. J.

N1 - Funding Information: Technical assistance was provided by the Alvin J. Siteman Cancer Center Tissue Procurement Core, the High Speed Cell Sorter Core, and the Molecular and Genomic Analysis Core at Washington University School of Medicine and Barnes-Jewish Hospital in St Louis, MO, which are all supported by the National Cancer Institute Cancer Center Support Grant P30CA91842. This work was supported by National Institutes of Health grant R01CA162086 (TJL), PO1CA101937 (TJL), K08HL116605 (JMK) and the Barnes Jewish Hospital Foundation (TJL), as well as the Doris Duke Charitable Foundation to Washington University (SMS, Clinical Research Fellow).

PY - 2014/12/11

Y1 - 2014/12/11

UR - http://www.scopus.com/inward/record.url?scp=84926657869&partnerID=8YFLogxK

U2 - 10.1038/leu.2014.235

DO - 10.1038/leu.2014.235

M3 - Letter

C2 - 25092143

AN - SCOPUS:84926657869

SN - 0887-6924

VL - 28

SP - 2403

EP - 2406

JO - Leukemia

JF - Leukemia

IS - 12

ER -

Primary acute myeloid leukemia cells with IDH1 or IDH2 mutations respond to a DOT1L inhibitor in vitro

Access to Document

Other files and links

Cite this